Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,249 | 309 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,231 | 41 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,202 | 44 | $0 (2022) |
| Amarin Pharma Inc. | $936.80 | 32 | $0 (2022) |
| Novo Nordisk Inc | $721.63 | 34 | $0 (2022) |
| Insmed, Inc. | $509.30 | 29 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $377.57 | 16 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $352.96 | 14 | $0 (2022) |
| Amgen Inc. | $346.98 | 15 | $0 (2022) |
| Bayer HealthCare Pharmaceuticals Inc. | $253.88 | 7 | $0 (2022) |
| Lilly USA, LLC | $222.35 | 12 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $22.54 | 1 | ABBVIE INC. ($22.54) |
| 2023 | $31.99 | 1 | ABBVIE INC. ($31.99) |
| 2022 | $3,335 | 144 | ABBVIE INC. ($775.67) |
| 2021 | $3,859 | 163 | AstraZeneca Pharmaceuticals LP ($675.72) |
All Payment Transactions
309 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/09/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: NEUROSCIENCE | ||||||
| 04/19/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $31.99 | General |
| Category: NEUROSCIENCE | ||||||
| 12/16/2022 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $6.83 | General |
| Category: Diabetes | ||||||
| 12/15/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: Cardiovascular | ||||||
| 12/13/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $26.61 | General |
| Category: NEUROSCIENCE | ||||||
| 11/30/2022 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $27.12 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/29/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, SYNJARDY | Food and Beverage | In-kind items and services | $30.31 | General |
| Category: DIABETES | ||||||
| 11/29/2022 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $6.12 | General |
| Category: Diabetes | ||||||
| 11/28/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Respiratory | ||||||
| 11/22/2022 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $31.84 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/21/2022 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $28.72 | General |
| Category: Neuroscience | ||||||
| 11/17/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $31.57 | General |
| Category: RESPIRATORY | ||||||
| 11/16/2022 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $32.54 | General |
| Category: Diabetes | ||||||
| 11/16/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $5.40 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $28.89 | General |
| Category: NEUROSCIENCE | ||||||
| 11/10/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/09/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $106.00 | General |
| 11/09/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: Cardiovascular | ||||||
| 11/09/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $10.78 | General |
| Category: RESPIRATORY | ||||||
| 11/09/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $6.72 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: Diabetes | ||||||
| 11/02/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $27.45 | General |
| Category: Cardio-renal | ||||||
| 10/27/2022 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $32.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/25/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Respiratory | ||||||
| 10/21/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 3 | 117 | 163 | $36,194 | $13,409 |
| 2021 | 2 | 31 | 39 | $6,806 | $3,280 |
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 61 | 86 | $22,062 | $7,904 | 35.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 44 | 65 | $13,612 | $5,366 | 39.4% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2022 | 12 | 12 | $519.60 | $139.76 | 26.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 18 | 24 | $6,157 | $2,951 | 47.9% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2021 | 13 | 15 | $649.50 | $329.71 | 50.8% |
About Christian Salinas
Christian Salinas is a Family healthcare provider based in San Francisco, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/16/2019. The National Provider Identifier (NPI) number assigned to this provider is 1619529989.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Christian Salinas has received a total of $7,249 in payments from pharmaceutical and medical device companies, with $22.54 received in 2024. These payments were reported across 309 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($7,249).
As a Medicare-enrolled provider, Salinas has provided services to 148 Medicare beneficiaries, totaling 202 services with total Medicare billing of $16,690. Data is available for 2 years (2021–2022), covering 5 distinct procedure/service records.
Practice Information
- Specialty Family
- Other Specialties Family, Family
- Location San Francisco, CA
- Active Since 07/16/2019
- Last Updated 04/26/2023
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1619529989
Products in Payments
- Vascepa (Drug) $936.80
- FARXIGA (Drug) $884.05
- QULIPTA (Drug) $446.55
- LINZESS (Drug) $428.52
- Arikayce (Drug) $417.84
- Ozempic (Drug) $356.57
- XARELTO (Drug) $352.96
- BREZTRI (Drug) $293.59
- Kerendia (Drug) $253.88
- UBRELVY (Drug) $201.54
- TRELEGY ELLIPTA (Drug) $188.60
- Aimovig (Biological) $174.40
- Otezla (Drug) $172.58
- RYBELSUS (Drug) $167.97
- TRULICITY (Drug) $164.79
- JARDIANCE (Drug) $147.53
- TRADJENTA (Drug) $138.04
- ENTRESTO (Drug) $131.45
- BOTOX (Biological) $125.00
- SOLIQUA 100/33 (Biological) $117.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in San Francisco
Annika Ehrlich, Ms, Rn, Fnp-C, MS, RN, FNP-C
Family — Payments: $81,176
Dr. Orlando Harris, Np-F, NP-F
Family — Payments: $29,820
Ms. Christine Garvey, Fnp, FNP
Family — Payments: $22,466
Nadine Wlasiuk, Aprn,Cpnp-Pc, Fnp-Bc, APRN,CPNP-PC, FNP-BC
Family — Payments: $16,522
Alicia Chang, Np, NP
Family — Payments: $6,430
Emily Craft
Family — Payments: $4,737